Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #3684574

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
1,510,000 EUR
354,000 EUR
Interest paid, classified as operating activities
115,000 EUR
169,000 EUR
Interest received, classified as operating activities
151,000 EUR
0 EUR
Cash flows from (used in) operating activities
1,596,000 EUR
615,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
275,000 EUR
213,000 EUR
Purchase of intangible assets, classified as investing activities
1,843,000 EUR
2,199,000 EUR
Cash flows from (used in) investing activities
2,118,000 EUR
2,412,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
9,182,000 EUR
4,310,000 EUR
Repayments of borrowings, classified as financing activities
1,053,000 EUR
1,921,000 EUR
Payments of lease liabilities, classified as financing activities
494,000 EUR
462,000 EUR
Cash flows from (used in) financing activities
7,081,000 EUR
1,609,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
3,367,000 EUR
1,419,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
19,000 EUR
13,000 EUR
Cash and cash equivalents
10,467,000 EUR
7,118,000 EUR
8,524,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.